Regulus Therapeutics Inc (NASDAQ:RGLS)

0.2325
Delayed Data
As of Jun 24
 -0.0276 / -10.61%
Today’s Change
0.16
Today|||52-Week Range
1.05
-26.19%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Regulus Therapeutics Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 0.50. The median estimate represents a +760.22% increase from the last price of 0.23.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Regulus Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.05
Sales
$0.00
Reporting Date
Aug 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -0.67%
 
 
 
 
 
 
Growthannually 39.30%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.